Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 20367078)

Published in J Neurosurg on August 01, 2010

Authors

Dali Yin1, R Mark Richardson, Massimo S Fiandaca, John Bringas, John Forsayeth, Mitchel S Berger, Krystof S Bankiewicz

Author Affiliations

1: Department of Neurosurgery, University of California, San Francisco, California 94103, USA.

Articles citing this

Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg (2011) 1.30

Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. Hum Gene Ther (2012) 1.02

Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy. Front Neuroanat (2014) 1.01

Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders. Hum Gene Ther (2010) 0.97

Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain. Neurobiol Dis (2011) 0.93

Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity. Acta Biomater (2015) 0.88

Which drug or drug delivery system can change clinical practice for brain tumor therapy? Neuro Oncol (2013) 0.88

Guided delivery of adeno-associated viral vectors into the primate brain. Adv Drug Deliv Rev (2011) 0.86

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model. Cancer Gene Ther (2013) 0.84

Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery. Ann Neurosci (2012) 0.82

Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications. Pharmaceuticals (Basel) (2012) 0.77

Gene therapy for misfolding protein diseases of the central nervous system. Neurotherapeutics (2013) 0.77

Rapid inverse planning for pressure-driven drug infusions in the brain. PLoS One (2013) 0.76

Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements. J Neurosci Methods (2010) 0.76

Articles by these authors

The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54

An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32

Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71

Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst (2005) 4.63

Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12

Glioma extent of resection and its impact on patient outcome. Neurosurgery (2008) 4.02

Functional outcome after language mapping for glioma resection. N Engl J Med (2008) 4.01

Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol (2002) 3.99

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91

Patterns of care for adults with newly diagnosed malignant glioma. JAMA (2005) 3.08

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol (2008) 2.92

High gamma activity in response to deviant auditory stimuli recorded directly from human cortex. J Neurophysiol (2005) 2.88

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71

Categorical speech representation in human superior temporal gyrus. Nat Neurosci (2010) 2.67

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol (2003) 2.63

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol (2007) 2.56

Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res (2010) 2.56

Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg (2007) 2.43

Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther (2012) 2.42

Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther (2006) 2.41

Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. J Neurosurg (2003) 2.24

Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro Oncol (2009) 2.23

Comanagement of surgical patients between neurosurgeons and hospitalists. Arch Intern Med (2010) 2.22

Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg (2010) 2.19

Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg (2013) 2.16

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15

Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg (2011) 2.14

Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery (2014) 2.11

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res (2004) 2.10

Neurostimulation for traumatic brain injury. J Neurosurg (2014) 2.10

Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg (2004) 2.08

Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg (2005) 2.07

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma. Neurosurgery (2015) 2.06

Symptomatic enlarged cervical anterior epidural venous plexus in a patient with Marfan syndrome. AJNR Am J Neuroradiol (2002) 2.05

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01

Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95

Five-dimensional neuroimaging: localization of the time-frequency dynamics of cortical activity. Neuroimage (2008) 1.88

Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg (2008) 1.79

Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics (2008) 1.79

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol (2005) 1.78

Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg (2007) 1.77

A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys. Mol Ther (2006) 1.77

Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc (2005) 1.74

Low-grade gliomas in adults. J Neurosurg (2011) 1.73

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet (2012) 1.73

Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther (2006) 1.72

Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease. Hum Gene Ther (2012) 1.70

Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci U S A (2009) 1.70

Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell (2011) 1.67

Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys (2009) 1.67

The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg (2010) 1.67

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg (2012) 1.64

Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg (2005) 1.63

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol (2003) 1.63

Magnetoencephalographic imaging of resting-state functional connectivity predicts postsurgical neurological outcome in brain gliomas. Neurosurgery (2012) 1.61

Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival. Surg Neurol Int (2010) 1.61

Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol (2004) 1.61

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol (2008) 1.59

An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. J Neurosci (2010) 1.59

Mapping functional connectivity in patients with brain lesions. Ann Neurol (2008) 1.58

mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol (2005) 1.56

Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther (2009) 1.55

Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg (2013) 1.55

Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther (2012) 1.55

Comparison of time-frequency responses and the event-related potential to auditory speech stimuli in human cortex. J Neurophysiol (2009) 1.54

Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol (2007) 1.53

Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage (2008) 1.53

Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. J Neurosurg (2010) 1.53

Quantifying accuracy and precision of diffusion MR tractography of the corticospinal tract in brain tumors. J Neurosurg (2014) 1.53

Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther (2013) 1.52

Comment on "Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension". Science (2007) 1.52

Homotopic organization of essential language sites in right and bilateral cerebral hemispheric dominance. J Neurosurg (2011) 1.51

Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease. Mol Ther (2011) 1.50

Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg (2010) 1.48